Ron Bentsur

Filings by Ron Bentsur span 2 companies, the busiest being Nuvectis Pharma, Inc. and Beyond Air, Inc. Over a trading history stretching from 22 November 2021 to 30 June 2026, the count stands at 61 filings.

In open-market terms, that means 54 purchases worth €1.8M on one side and 2 sales worth €620k on the other. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants and 1 option exercise. 2026 to date brings 1 purchase and no sales.

Half of the purchases are above €5,409 and half below. On 33 out of 54 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 1 July 2026 with an open-market purchase in Nuvectis Pharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.